Head to Head Comparison: ASP Isotopes (NASDAQ:ASPI) & Kiwa Bio-Tech Products Group (OTCMKTS:KWBT)

ASP Isotopes (NASDAQ:ASPI) and Kiwa Bio-Tech Products Group (OTCMKTS:KWBT) are both basic materials companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, institutional ownership, valuation and risk.

Analyst Recommendations

This is a breakdown of recent recommendations for ASP Isotopes and Kiwa Bio-Tech Products Group, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ASP Isotopes	1	0	2	0	2.33
Kiwa Bio-Tech Products Group	0	0	0	0	0.00

ASP Isotopes presently has a consensus price target of $13.00, suggesting a potential upside of 146.21%. Given ASP Isotopes’ stronger consensus rating and higher possible upside, equities analysts clearly believe ASP Isotopes is more favorable than Kiwa Bio-Tech Products Group.

Institutional & Insider Ownership

16.8% of ASP Isotopes shares are owned by institutional investors. 14.4% of ASP Isotopes shares are owned by company insiders. Comparatively, 1.3% of Kiwa Bio-Tech Products Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Earnings & Valuation

This table compares ASP Isotopes and Kiwa Bio-Tech Products Group”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ASP Isotopes	$4.14 million	141.36	-$32.33 million	($1.30)	-4.06
Kiwa Bio-Tech Products Group	N/A	N/A	N/A	N/A	N/A

Kiwa Bio-Tech Products Group has lower revenue, but higher earnings than ASP Isotopes.

Profitability

This table compares ASP Isotopes and Kiwa Bio-Tech Products Group’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
ASP Isotopes	-1,259.12%	-190.44%	-77.22%
Kiwa Bio-Tech Products Group	N/A	N/A	N/A

Summary

ASP Isotopes beats Kiwa Bio-Tech Products Group on 6 of the 9 factors compared between the two stocks.

About ASP Isotopes

ASP Isotopes Inc., a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc. was incorporated in 2021 and is headquartered in Washington, District Of Columbia.

About Kiwa Bio-Tech Products Group

Kiwa Bio-Tech Products Group Corporation, together with its subsidiaries, develops, manufactures, markets, and distributes bio-technological products for the agricultural market primarily in the People's Republic of China. It offers bacillus species and/or photosynthetic bacteria based biological organic, compound microbial, bio-water soluble, and microbial inoculum fertilizers. The company has a strategic cooperation agreements with the Beijing Zhongpin Agricultural Science and Technology Development Center; China Academy of Agricultural Science's Institute of Agricultural Resources & Regional Planning; and Institute of Agricultural Economy & Development, as well as Kiwa Bio-Tech (Yangling) Co. Ltd. Kiwa Bio-Tech Products Group Corporation was founded in 2002 and is headquartered in Yangling, China.